Results 11 to 20 of about 101,541 (346)

Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest

open access: yesClinical pharmacology and therapy, 2022
In response to a surge of deaths from synthetic opioid overdoses, there have been increased efforts to distribute naloxone products in community settings.
J. Mann   +15 more
semanticscholar   +1 more source

Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs

open access: yesBMC Health Services Research, 2023
Background Opioid overdose fatalities are preventable with timely administration of naloxone, an opioid antagonist, during an opioid overdose event. Syringe service programs have pioneered naloxone distribution for potential bystanders of opioid overdose.
Sheila V. Patel   +6 more
doaj   +1 more source

The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews.

open access: yesAmerican Journal of Public Health, 2021
Background. Opioids contribute tomore than 60 000 deaths annually in North America. While the expansion of overdose education and naloxone distribution (OEND) programs has been recommended in response to the opioid crisis, their effectiveness remains ...
Amir Razaghizad   +8 more
semanticscholar   +1 more source

Practical implications of naloxone knowledge among suburban people who use opioids

open access: yesHarm Reduction Journal, 2021
Background Naloxone distribution programs have been a cornerstone of the public health response to the overdose crisis in the USA. Yet people who use opioids (PWUO) continue to face a number of barriers accessing naloxone, including not knowing where it ...
Kristin E. Schneider   +6 more
doaj   +1 more source

Pharmacy Students’ Perceptions and Stigma Surrounding Naloxone Use in Patients with Opioid Use Disorder: A Mixed Methods Evaluation

open access: yesPharmacy, 2020
Pharmacists represent a key group of healthcare professionals that can increase awareness and destigmatize naloxone use. The objective of this study was to investigate pharmacy student perceptions of the use, dispensing, and stigma surrounding naloxone ...
Alina Cernasev   +4 more
doaj   +1 more source

Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study.

open access: yesPLoS ONE, 2021
IntroductionTake-Home Naloxone programs have been introduced across North America in response to rising opioid overdose deaths. There is currently limited real-world data on bystander naloxone administration, overdose outcomes, and evidence related to ...
Amina Moustaqim-Barrette   +6 more
doaj   +2 more sources

Naloxone Hypertension

open access: bronzeAnesthesia & Analgesia, 1980
K, Patel, S, Gelman
openaire   +3 more sources

Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment

open access: yesHarm Reduction Journal, 2023
Background Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in ...
Zofia Kozak   +11 more
doaj   +1 more source

Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another

open access: yesPharmacy, 2021
A recent report found that the number of opioid-related deaths in Ontario in the first 15 weeks of the COVID-19 pandemic was 38.2% higher than in the 15 weeks before the pandemic.
George Daskalakis   +3 more
doaj   +1 more source

Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration

open access: yesHarm Reduction Journal, 2022
Background Emergency departments (EDs) are important venues for the distribution of naloxone to patients at high risk of opioid overdose, but less is known about patient perceptions on naloxone or best practices for patient education and communication ...
Margaret Lowenstein   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy